[Value of the sequential treatment with defibrinating agents and plasminogenic urokinase in thromboembolic disease].
D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D013923:Thromboembolism / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D006493:Heparin
Intérêt du traitement séquentiel par défibrinant et plasminogène urokinase dans la maladie thromboembolique.